Диссертация (1139693), страница 28
Текст из файла (страница 28)
2009;24:1601–1607.114. Hamilton M. The assessment of anxiety states by rating // Br. J. Med. Psychol.– 1959. – Vol. 32. – P. 50-55115. Hamilton M. A rating scale for depression // Journal of Neurology,Neurosurgery and Psychiatry. – 1960. – Vol. 23. – P. 56-62116. Hausteiner-Wiehle Constanze, Henningsen Peter. Irritable bowel syndrome:Relations with functional, mental, and somatoform disorders.
World JGastroenterol. 2014 May 28; 20(20): 6024–6030117. Hemarajata P., Versalovic J. Effects of probiotics on gut microbiota:mechanisms of intestinal immunomodulation and neuromodulation. Therap AdvGastroenterol. 2013 Jan; 6(1): 39–51118. Hemaiswarya S., Raja R., Ravikumar R., Carvalho I.S. Mechanism of action ofprobiotics. Braz. arch. biol. technol. vol.56 no.1 Curitiba Jan./Feb. 2013119. Hodes GE, Ménard C, Russo SJ.
Integrating Interleukin-6 into depressiondiagnosis and treatment. Neurobiol Stress. 2016 Mar 29;4:15-22.120. Hoffman JM, et al. Activation of colonic mucosal 5-HT(4) receptorsacceleratespropulsivemotilityandinhibitsvisceralhypersensitivity.240Gastroenterology. 2012; 142:844–854121. Hosseini A., Nikfar S., Abdollahi M. Probiotics use to treat irritable bowelsyndrome // Expert Opin. Biol.
Ther. – 2012. – Vol. 12. – P. 1323-34122. Howard Mertz Altered CNS Processing of visceral pain in IBS in IrritableBowel Syndrome. Diagnosos and treatment. Edited by Michael Camilleri, Robin CSpiller 2002123. Hua Chu, Mark Fox, Xia Zheng, Yanyong Deng, Yanqin Long, Zhihui Huang,Lijun Du, Fei Xu, Ning Dai.
Small Intestinal Bacterial Overgrowth in Patients withIrritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, andPeripheral Cytokines. Gastroenterology Research and Practice Volume 2016(2016), Article ID 3230859, 8 pages124. Ivashkin V., Drapkina O., Poluektova Ye., Kuchumova S., Sheptulin A.,Shifrin O.
The Effect of a Multi-strain Probiotic on the Symptoms and SmallIntestinal Bacterial Overgrowth in Constipation-predominant Irritable BowelSyndrome: A Randomized, Simple-blind, Placebo-controlled Trial. AmericanJournal of Clinical Medicine Research, 2015, Vol. 3, No. 2, 18-23.125.
James J. Galligan, Hamid I. Akbarali. Molecular Physiology of Enteric OpioidReceptors. Am J Gastroenterol. 2014 September 10; 2(1): 17–2126. Jeffery IB, O'Toole PW, Öhman L, Claesson MJ, Deane J, Quigley EM,Simrén M. An irritable bowel syndrome subtype defined by species-specificalterations in faecal microbiota. Gut 2012 Jul;61(7):997-1006127.
Jiang H, Ling Z, Zhang Y. Altered fecal microbiota composition in patientswith major depressive disorder. Brain Behav Immun. 2015 Aug;48:186-94128. Jizhong S, Qiaomin W, Chao W. Corticotropin-Releasing Factor and Toll-LikeReceptor Gene Expression Is Associated with Low-Grade Inflammation in IrritableBowelSyndromePatientswithDepression.GastroenterolResPract.2016;2016:7394924129. Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U.Oral bisacodyl is effective and well-tolerated in patients with chronic constipation.Clin Gastroenterol Hepatol.
2011 Jul;9(7):577-83.241130. Katsui R, et al. A new possibility for repairing the anal dysfunction bypromoting regeneration of the reflex pathways in the enteric nervous system. Am JPhysiol Gastrointest Liver Physiol. 2008; 294:G1084–G1093131. Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment ofirritable bowel syndrome: a systematic review and meta-analysis. J ClinGastroenterol. 2014 Jul;48(6):505-12132. Koçak E, Akbal E, Köklü S, Ergül B, Can M. The Colonic Tissue Levels ofTLR2, TLR4 and Nitric Oxide in Patients with Irritable Bowel Syndrome.133. Koloski NA et al.
The brain-gut pathway in functional gastrointestinaldisorders is bidirectional: a 12-year prospective population-based study. Gut.2012;61:1284-90134. Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowelsyndrome in Denmark. A population-based survey in adults ≤ 50 years of age.Scand J Gastroenterol. 2013;48:523–529.135. Kurbatova A., Poluektova E., Demura T.,Kuchumova S., Konkov M.,GorevM., Sheptulin A., Kogan E., Shifrin O. Ivashkin V. Cytokines and tight junctionproteins expression changes in patients with irritable bowel syndrome.Gastroenterology 2013, Volume 142, Issue 5, Supplement 1, Page S-807136.
Layer P., Andresen V., et al. Guideline Irritable Bowel Syndrome: Definition,Pathophysiology, Diagnosisand Therapy. Joint Guideline of the German Societyfor Digestive and Metabolic Diseases (DGVS) and the German Society forNeurogastroenterology and Motility (DGNM). Z Gastroenterol 2011; 49:237-93137. Lee H.J., Lee S.Y., Choi J.E.
et al. G protein beta3 subunit, interleukin-10, andtumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowelsyndrome // Neurogastroenterol Motil. – 2010. – Vol. 22. - № 7. – p. 758-63.138. Lee YY, Waid A, Tan HJ, Chua AS, Whitehead WE. Rome III survey ofirritable bowel syndrome among ethnic Malays. World J Gastroenterol.2012;18:6475–6480; discussion p. 6479.139. Lee B.J., Bak Y.T. Irritable bowel syndrome, gut microbiota and probiotics // J.Neurogastroenterol.
Motil. – 2011. – Vol. 17. – P. 252-66242140. Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015 Oct;13(4): 306–312.141. Lee HJ, Choi JK, Ryu HS. Therapeutic Modulation of Gut Microbiota inFunctional Bowel Disorders. Neurogastroenterol Motil, Vol. 23 No. 1 January,2017142. Lembo A.J., Lacy B.E., Zuckerman M.J. et.al. Eluxadoline for Irritable BowelSyndrome with Diarrhea. N Engl. J.Med. 2016 Jan 21;374(3):242-53143. Lembo A., Lavins B.J., MacDougall J.E. et al. Assesing adequate reliev-basedthresholds for abdominal and bowel symptoms in two phase 3 trials of linaclotidefor irritable bowel syndrome with constipation. UEG J.
2013; 1 (Suppl.: 21UEGW: Abstracts): A48144. Lessa F.C., Mu Y., Bamberg W.M., Beldavs Z.G., Dumyati G.K., Dunn J.R.,Farley M.M., Holzbauer S.M., Meek J.I., Phipps E.C., et al. Burden of Clostridiumdifficile infection in the united states. N Engl J Med 2015; 372:825-34145. Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, Downie-DoyleS, Smith E, Drew P, Talley NJ, et al. Immune activation in patients with irritablebowel syndrome. Gastroenterology. 2007; 132 :913–920146. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 5-HT4 receptor-mediatedneuroprotection and neurogenesis in the enteric nervous system of adult mice. JNeurosci.
2009; 29:9683–9699.147. Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD. Expression and functionof 5-HT4 receptors in the mouse enteric nervous system. Am J PhysiolGastrointest Liver Physiol. 2005; 289:G1148–G1163148. Lobo B., Vicario M., Martinez C. et al. Clinical improvement in IBS afterdisodium cromoglycate involves mast cell-mediated toll-like receptor signalingdownregulation // Gut. – 2010. – Vol. 59. - A52.149. Locke GR 3RD et al.
Psychosocial factors are linked to functionalgastrointestinal disorders: a population based nested case-control study. Am JGastroenterol. 2004;99:350-7150. Longstreth G.F., Thompson W.G., Chey W.D. et al. Functional bowel243disorders. Gastroenterology. 2006; 130: 1480—91151. Lucas A., Cobelens P.M., Kavelaars A. et al. Disturbed in vitro adrenergicmodulation of cytokine production in inflammatory bowel diseases in remission //J Neuroimmunol. – 2007. – Vol.
182. - №1. – p. 195-203.152. Maddock C., Baita A., Orru M.G. et al. Psychopharmacological treatment ofdepression, anxiety, irritability and insomnia in patients receiving interferon-alpha:a prospective case series and a discussion of biological mechanisms //J.Psychopharmacol. – 2004. – Vol. 18. – p. 41-46.153. Maier, S.F., Watkins, L.R. Cytokines for psychologists: Implications ofbidirectional immune-tobrain communication for understanding behavior, mood,and cognition // Psychological Review.
– 1998. – Vol. 105. – p. 83-107.154. Makino S., Hasimoto K., Gold P.W. Multiple feedback mechanisms activatingcorticotropin-releasing hormone system in the brain during stress. // PharmacolBiochem Behav. 2002. – Vol.73, pp.147-158.155. Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome:A systematic review of systemic and mucosal inflammatory mediators. Dig Dis.2016 Sep;17(9):572-581156. Matsuyoshi H, et al. A 5-HT(4)-receptor activation-induced neural plasticityenhances in vivo reconstructs of enteric nerve circuit insult. NeurogastroenterolMotil. 2010; 22:806–813157.
Mete R., Tulubas F., Oran M. et al. The role of oxidants and reactive nitrogenspecies in irritable bowel syndrome: a potential etiological explanation // Med. Sci.Monit. – 2013. – Vol. 13. – P. 762-6158. Miller, A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoidreceptorexpression and function // Advances in Experimental Medicine andBiology. – 1999.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
